U.S. Metals and Mining Stock News

If you are wondering whether Natural Resource Partners at US$118.78 is offering value or asking too much, you are in the right place for a clear valuation check. The stock has returned 3.2% over the last week, is roughly flat over the past month with a 0.9% decline, and has returns of 14.2% year to date and 18.8% over the last year. Recent coverage has focused on Natural Resource Partners as a long term compounder, with attention on its multi year share price performance and capital...

Active Energy Group plc recently signed a non-binding Letter of Intent with Bitdeer Middle East Technology Ltd., a Bitdeer Technologies Group subsidiary, to form a profit-sharing joint mining partnership that combines Active Energy’s 100MW-targeted, ultra-low-cost power and infrastructure with Bitdeer’s mining equipment and operational expertise. This arrangement is structured so each party keeps ownership of its own assets, potentially allowing Bitdeer to expand mining exposure through a...

Next Technology Holding (NasdaqCM:NXTT) opened 2026 with Q1 revenue of about US$0.5 million and a basic EPS loss of US$1.39 per share, alongside a net loss of US$105.9 million. Over recent quarters the company has seen revenue move from US$0 in Q1 2025 to US$9.8 million in Q4 2025 before landing at US$0.5 million in Q1 2026. EPS has swung from a very high profit of US$396.38 per share in Q1 2025 to a loss of US$1.39 in the latest quarter, setting a backdrop where reported margins look highly...

Brookfield Infrastructure (NYSE:BIPC) has opened 2026 with Q1 revenue of US$884 million and a basic EPS loss of US$0.93, setting the tone for another quarter where the income statement matters more than headline growth stories. Over the past year, quarterly revenue has ranged from US$866 million to US$956 million while EPS has swung between a gain of US$3.27 and a loss of US$4.01, highlighting how volatile profitability has been for shareholders watching margins. See our full analysis for...

Why the Maeve refinancing matters for Walker & Dunlop stock Walker & Dunlop (WD) recently arranged a US$105 million refinancing loan for Maeve, a 297 unit luxury high rise in Raleigh’s Warehouse District, located in a federally designated opportunity zone. This transaction highlights the company’s role in large multifamily financings tied to tax advantaged opportunity zone projects. It gives investors another concrete example of the type of assets that sit behind Walker & Dunlop’s capital...

Wondering whether Blackbaud at around US$37.54 is a bargain or a value trap? This breakdown will help you size up what the current share price really reflects. The stock has been broadly flat over the last month at around 0.0%. However, that sits against a much tougher backdrop with a 36.9% decline year to date and a 38.9% decline over the past year. Those longer term returns mean many holders are sitting on losses, which often pushes valuation questions to the front of investors' minds...

Pro-Dex (PDEX) has put up a solid Q3 2026 print, with revenue of about US$19.9 million and basic EPS of roughly US$1.23, against a trailing twelve month backdrop where earnings grew 28.1% year over year and net profit margin sat at 16.1%. Over recent quarters the company has seen revenue move from around US$17.4 million in Q3 2025 to US$19.9 million in Q3 2026, while quarterly basic EPS ranged between roughly US$0.37 and US$1.43 over that stretch, giving a clear view of how revenue and per...

American International Group (AIG) opened 2026 with Q1 results that put the focus squarely on the income statement, as revenue came in at US$6.7b and basic EPS landed at US$1.42 on net income of US$763m. The company has seen revenue move from US$6.5b in Q1 2025 to US$6.7b in Q1 2026, while basic EPS over that stretch ranged from US$1.18 in Q1 2025 to US$1.42 in the latest quarter. This sets the stage for investors to weigh these headline figures against a backdrop of improving trailing net...

Encompass Health (EHC) is back in focus after reporting first quarter results that topped analyst expectations on revenue and earnings, and after management raised full year 2026 guidance for the business. See our latest analysis for Encompass Health. The strong first quarter beat and raised 2026 guidance were followed by a 7.48% 1-day share price return, contributing to a 10.37% 30-day share price return. The 1-year total shareholder return remains a 7.24% decline and the 3-year total...

IMAX (IMAX) has opened 2026 with Q1 revenue of US$81.4 million and basic EPS of US$0.08, setting a clear marker for how the year is starting to shape up against expectations. Over recent quarters the company has seen revenue move from US$86.7 million in Q1 2025 to US$125.2 million in Q4 2025 before landing at US$81.4 million in Q1 2026, while basic EPS has ranged from US$0.04 to US$0.38 over the same period. This gives you a fuller view of how the top and bottom lines have tracked into the...

OneSpan (OSPN) Q1 2026 earnings snapshot OneSpan (OSPN) has opened 2026 with Q1 revenue of US$65.9 million and basic EPS of US$0.31, setting the tone for investors assessing how the business is converting its software demand into bottom line results. Over the past year, the company has seen trailing twelve month revenue sit at US$245.8 million with basic EPS of US$1.84, alongside earnings growth of 20.4% and net margins at 28.5% compared to 24% a year earlier. This provides useful context for...

LPL Financial Holdings (LPLA) opened 2026 with Q1 revenue of about US$4.8b and basic EPS of US$4.45, as investors weigh these headline figures against a reported net margin of 5% over the trailing 12 months that was affected by a US$732.0m one off loss. The company has seen quarterly revenue move from US$3.4b in Q4 2024 to US$3.6b in Q1 2025 and then to about US$4.8b in Q1 2026. Over the last six reported periods, trailing 12 month basic EPS has ranged from US$14.17 to US$11.25, placing...

Recent performance snapshot UMH Properties (UMH) has drawn attention after its recent trading action, with the stock last closing at $15.74 and showing mixed return patterns over the past year and past 3 months. See our latest analysis for UMH Properties. The recent 7.66% 1 month share price return contrasts with a 1 year total shareholder return decline of 6.33% and a 3 year total shareholder return of 18.54%, suggesting momentum has picked up again after a weaker stretch. If this kind of...

Jade Biosciences (NasdaqCM: JBIO) appointed Edward R. Conner, M.D. as Chief Medical Officer. The company elevated Andrew King, M.D., Ph.D. to President, Research & Development. These leadership changes focus on clinical development, regulatory strategy, and R&D continuity for Jade's autoimmune pipeline. Jade Biosciences, listed on NasdaqCM under the ticker JBIO, is focused on developing therapies for autoimmune conditions, an area that continues to attract capital and partnerships across...

Trustmark stock: key context for investors Trustmark (TRMK) continues to draw attention after recent trading, with shares last closing at $44.91 and a market value of about $2.6b, putting the regional bank firmly on many investors’ watchlists. See our latest analysis for Trustmark. Recent trading has added to that interest, with a 1-day share price return of 1.22% and a year-to-date share price return of 14.89%, alongside a 1-year total shareholder return of 31.86% and a 3-year total...

PBF Energy (PBF) opened 2026 with Q1 revenue of US$7.9b and basic EPS of US$1.69, alongside net income excluding extra items of US$198.3m, setting a clear marker after a volatile run of recent quarters. The company has seen quarterly revenue move from US$7.1b in Q1 2025 to US$7.9b in Q1 2026, while EPS shifted from a loss of US$3.53 in Q1 2025 to a profit of US$1.69 in the latest period. This points to a very different margin profile as investors gauge how durable this reset may be. See our...

Coherent overview and recent performance snapshot Coherent (COHR) has drawn investor attention after a sharp move in its share price, with recent data showing a month return of 32.97% and a past 3 months return of 55.29%. The stock closed at US$329.50, with year to date and 1 year total returns of 69.56% and 359.94% respectively, alongside reported annual revenue of US$6.29b and net income of US$192.23m. See our latest analysis for Coherent. Coherent’s recent 1 day share price return of 3.06%...

Wondering whether Delta Air Lines at around US$68.98 is offering good value or stretching expectations? This article will help you size up the stock through a clear valuation lens. The share price has moved by 0.8% over the last 7 days and 2.0% over the last 30 days, with a 1 year return of 58.0% and a 3 year return of 109.5%, while the year to date figure sits at a slight 0.1% decline. Recent headlines have focused on Delta Air Lines in the context of broader airline sector themes,...

Pool (POOL) has drawn fresh attention after its board expanded the share repurchase program to US$600.0m and lifted the quarterly dividend by 4% to US$1.30 per share, signaling shareholder friendly capital returns. See our latest analysis for Pool. Even with the enlarged buyback and higher dividend, Pool’s recent price action has been weak, with a 10.52% 7 day share price return decline and a 30.87% 1 year total shareholder return decline. This points to fading momentum despite steady recent...

Investors may be wondering whether Aurora Innovation's share price reflects its true worth, or if the market is mispricing the story right now. The stock recently closed at US$6.13, with returns of 24.8% over 7 days, 46.7% over 30 days, 58.4% year to date, and a 24.7% decline over the past year, alongside a very large gain over 3 years. Recent coverage has focused on how autonomous driving and AI related names are being reassessed by investors, as attention shifts to companies tied to real...

If you are wondering whether Corcept Therapeutics at around US$51.42 is attractively priced or already stretched, starting with a clear view of valuation can help frame your next move. The stock has seen sharp swings recently, with returns of 11.6% over 7 days, 22.5% over 30 days, 34.6% year to date, but a 29.3% decline over the past year and gains of 113.6% over 3 years and 143.7% over 5 years. Recent coverage has focused on how this price history shapes expectations for Corcept...

Recent share performance and business snapshot Without a specific headline event setting the tone, ACADIA Pharmaceuticals (ACAD) is drawing attention for its recent share performance and current fundamentals, which some investors may see as a prompt to reassess the stock. The company has a market value of about US$3.8b and last closed at US$21.95. Recent returns have been mixed, with a small move over the past week, a modest decline over the month, and a larger negative move over the past 3...

For investors considering whether Travelers Companies at around US$304.72 represents fair value or whether the price may be ahead of itself, this article examines what the available numbers indicate about the stock. The share price has moved by 0.7% over the past week, 4.9% over the last month, 6.8% year to date and 15.8% over the past year. These figures provide useful context before assessing the underlying value. Recent news coverage has focused on Travelers Companies as a major U.S...

What Airbnb’s recent performance signals for investors Without a specific news headline driving attention, Airbnb (ABNB) is on investors’ radar as its share price, recent returns, and profitability metrics offer fresh context for assessing the short term trade off between growth and value. See our latest analysis for Airbnb. With the share price at US$141.66 after a positive 1 day share price return of 0.93%, recent momentum has been shaped more by the 13.16% 30 day share price return and a...